This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

ChinaBio™ Partnering Forum
April 28–29, 2026
Kerry Hotel Pudong, Shanghai, ChinaMay 6–7, 2026 - Digital Partnering
Menu

Pitch your company at this year's Startup Spotlight

This exciting competition offers innovative entrepreneurs a chance to pitch their company at ChinaBio™ Partnering Forum 2026.

Applications for the Startup Spotlight at ChinaBio Partnering Forum have now closed.

2026 Startup Spotlight winner

Congratulations to the Startup Spotlight at ChinaBio™ Partnering Forum 2026 winner, NeuroVanda Therapeutics.

Built on deep insights into disease biology, NeuroVanda focuses on the development of transformational oral therapies targeting the most important drivers of neurodegenerative diseases. We have established a proprietary targeted protein degradation platform leveraging a differentiated E3 ligase which offers superior selectivity and efficiency in clearing aggregated proteins.

Thank you to Pfizer for sponsoring this year's competition again, and to all our other finalists and entries.



What to expect

Selected companies will have the opportunity to make a 6-minute pitch and participate in a live feedback session with a jury of leading investors, pharma dealmakers, and biotech business key opinion leaders who will evaluate the pitches and select the winner onsite in Shanghai, China.

Pitching Benefits

  • Visibility: Generate interest among the global life science audience attending ChinaBio™ Partnering Forum.
  • A complimentary registration and request one-to-one meetings, facilitated by partneringONE™, with investors and other attendees.
  • Startup Spotlight Winner —
    • Selected by judges: A complimentary registration to attend a future EBD event.

    • 500,000 RMB in-kind sponsorship provided by ATLATL including but not limiting to facility rent exemption, CRO service discount, etc., subject to final agreement signed by both parties.

Pitching Criteria

Applications can be submitted by companies that meet the following eligibility criteria:

  • Company created in the past three years, or innovation incubated within a company for a maximum of three years.
  • Developing new therapeutic solutions, technology and digital platforms.
  • Aggregate funding of 10 million USD or less.
  • Company with less than 20 employees.

Fee Structure

  • Pitch fee: $195.00

*Qualifying criteria must be met for this rate

Kevin Maskell

Bioarchitech

“The ChinaBio™ Partnering Forum Startup Spotlight competition significantly raised our visibility with both investors and pharma partners. The calibre and diversity of the entries were outstanding. Winning the competition and having our social media post widely shared within our field led to meaningful follow-up and new opportunities.”